BioVie, Inc. (BIVI)
1.625
+0.02
(+0.93%)
USD |
NASDAQ |
Sep 21, 16:00
1.625
0.00 (0.00%)
After-Hours: 20:00
BioVie Price : 1.625 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 1.78 | 1.84 | 1.61 | 1.61 | 406800.0 |
| Sep 17, 2026 | 1.82 | 1.841 | 1.75 | 1.78 | 478847.0 |
| Sep 16, 2026 | 1.76 | 1.825 | 1.685 | 1.72 | 439984.0 |
| Sep 15, 2026 | 1.90 | 1.908 | 1.565 | 1.75 | 1.155M |
| Sep 14, 2026 | 1.90 | 2.12 | 1.88 | 2.05 | 630141.0 |
| Sep 11, 2026 | 1.92 | 2.02 | 1.91 | 1.93 | 170760.0 |
| Sep 10, 2026 | 1.95 | 1.99 | 1.89 | 1.91 | 261851.0 |
| Sep 09, 2026 | 2.04 | 2.12 | 1.90 | 1.97 | 351368.0 |
| Sep 08, 2026 | 2.055 | 2.20 | 2.00 | 2.07 | 320029.0 |
| Sep 04, 2026 | 2.04 | 2.08 | 1.96 | 2.00 | 296762.0 |
| Sep 03, 2026 | 2.02 | 2.120 | 2.005 | 2.03 | 250794.0 |
| Sep 02, 2026 | 2.25 | 2.27 | 2.000 | 2.03 | 519400.0 |
| Sep 01, 2026 | 2.30 | 2.45 | 2.18 | 2.24 | 486559.0 |
| Aug 31, 2026 | 2.374 | 2.49 | 2.28 | 2.28 | 1.552M |
| Aug 28, 2026 | 2.20 | 2.25 | 2.106 | 2.16 | 485693.0 |
| Aug 27, 2026 | 2.09 | 2.22 | 2.00 | 2.19 | 763384.0 |
| Aug 26, 2026 | 2.005 | 2.25 | 1.967 | 2.11 | 922448.0 |
| Aug 25, 2026 | 2.00 | 2.11 | 1.93 | 2.09 | 1.030M |
| Aug 24, 2026 | 1.812 | 2.145 | 1.76 | 2.14 | 2.174M |
| Aug 21, 2026 | 2.155 | 2.48 | 1.80 | 1.95 | 19.76M |
| Aug 20, 2026 | 1.545 | 2.39 | 1.490 | 1.86 | 49.11M |
| Aug 19, 2026 | 1.30 | 1.44 | 1.14 | 1.34 | 42.47M |
| Aug 18, 2026 | 1.13 | 1.14 | 0.945 | 0.9644 | 10.54M |
| Aug 17, 2026 | 1.32 | 1.56 | 1.17 | 1.17 | 2.765M |
| Aug 14, 2026 | 1.415 | 1.515 | 1.245 | 1.40 | 2.119M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 8.31 |
| Amgen, Inc. | 393.44 |
| Anika Therapeutics, Inc. | 20.72 |
| BioCryst Pharmaceuticals, Inc. | 8.76 |
| Imunon, Inc. | 1.42 |
Price Related Metrics
| Price to Book Value | 1.193 |
| Earnings Yield | -196.8% |
| Market Cap | 12.26M |